Effects of inorganic mercury have been studied on the drug metabolizing enzymes (DME) of phenobarbitone- (PB-) and promethazine- (PM-) pretreated male New Zealand white rabbit, Oryctolagus cunciculus. After PB treatment, the activities of cytochrome p-450 (CP), aniline hydroxylase (AH), acetanilide hydroxylase (AAH), benzphatamine demethylase (BD), aminopyrine demethylase (APD) and N.N dimethyl aniline demethylase (DAD) increased 214, 266, 207, 108, 81 and 83%, respectively. Cytochrome-C-reductase (CCR) also increased 109%. However, the activities of cytochrome b5 (CB) and N.N dimethyl aniline N-oxide (DAO) decreased 76% and 38%, respectively. PM administration had no effect on any of the DMEs except for AH, AAH and BD, which showed 60, 5 and 16% increase, respectively. HgCl2 administered at a dose of 1mg/kg body wt per day for 5 days did not affect the CP, CB, APD and CCR. The activities of AH and AAH increased 32 and 33%, respectively, whereas those of BD, DAD, and DAO decreased 35%, 30% and 32%, respectively. When administered to PB-pretreated animals CP, AH, AAH, BD, APD, DAD, CCR, and DAO were inhibited 57, 58, 42, 31, 56, 55, 76 and 59%, respectively. Activity of CB increased 351%. HgCl2 had no effect on CP and CCR when administered to PM-pretreated animals. AH, AAH and CB increased 17, 135 and 30%, respectively. BD, APD and DAD were reduced 47, 10 and 19, respectively. Formation of DAO was also inhibited 52%. To conclude, mercury drastically interferes with the DME. The metabolism of PB is inhibited, whereas that of PM is variably affected – hydroxylases are up-regulated and demethylases are down-regulated. CB is however, induced 351% after mercury treatment.